Cogent Holdings Ltd: Seize the opportunity October 21, 2016 744

PSR Recommendation: BUY Status: Maintained
Target Price: 1.11
  • Resignation of GM does not materially affect ongoing business
  • Progress made on Jurong Island Chemical Logistics Facility project
  • Price weakness presents an opportunity to accumulate – reiterate BUY

 

What is the news?

Earlier this week on Monday, the price of Cogent Holdings Ltd (Cogent) stock shed 7.3% to close at 76 cents. Cogent subsequently made two announcements – one on Tuesday, and the other on Wednesday. The first announcement was pertaining to the resignation of its General Manager, Chairman’s Office, and the second was an update to the Jurong Island Chemical Logistics Facility project.

For context, we remind investors that Cogent Jurong Island Pte Ltd (CJI), a wholly-owned subsidiary of Cogent, had received a letter of offer from JTC Corporation (JTC) dated 6 September 2016 for Phase One of the construction of the Jurong Island Chemical Logistics Facility. Cogent had accepted the letter on 8 September 2016.

 

How do we view this?

  • Business as usual: Resignation of GM does not materially affect ongoing business

As disclosed in the announcement, the General Manager (GM) is “responsible for assisting the Chairman in all matter relating to the operations of the Group. His job responsibilities include liaising with the management staff and executing management plans assigned by the Chairman.”

The Chairman, was then concurrently the Chief Executive Officer (CEO) until December 2014. Thereafter, a new CEO was appointed in January 2015 and has fully taken over the responsibility of setting Group strategy. We understand from Management that there will not be a replacement for the vacant GM role. We do not view the GM’s departure as having any material adverse impact to the Group’s ongoing business.

  • Business on track: Progress made on Jurong Island Chemical Logistics Facility project

The update disclosed that Cogent “is currently working with various consultants and the relevant authorities towards constructing the Jurong Island Chemical Logistics Facility.”

For the avoidance of doubt, Cogent has physically taken over the land at Tembusu Crescent and the project will be executed. We have learnt that activities leading up to construction of the facility include inviting quotations to tender for the project, and selection of the main contractor. We retain our existing forecast in our previous report (13 September), for construction to commence in 2HFY17, with Phase One receiving its Temporary Occupation Permit (TOP) in 1HFY19.

We again highlight that Phase One and Phase Two combined of the Jurong Island Chemical Logistics Facility will be just as large (c.150,000 sqm) as the existing Cogent 1.Logistics Hub. We expect a material positive impact to earnings when contribution from the Jurong Island Chemical Logistics Facility starts to flow through to the bottom line. As such, we view this project positively.

Our expectations is for impact to earnings to come only in FY19, coinciding with TOP for Phase One. An earlier than expected completion of the project would be a positive welcome for the stock. Conversely, execution risk would be the de-rating factor.

 

Maintain “Buy” rating with unchanged DDM-backed target price of S$1.11

While current forecasted dividend yield of 3.2% is modest, investors can look for capital appreciation that is underpinned by earnings growth from the project. Our target price gives an implied forward P/E multiple of 15.6x over next-twelve-months (NTM) 7.13 cents EPS.

We again recommend investors to accumulate on price weakness. Reiterate “BUY”.

 

1

 

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

About the author

Profile photo of Richard Leow

Richard Leow
Research Analyst
Phillip Securities Research Pte Ltd

Richard covers the Transport Sector and Industrial REITs. He graduated with a Master of Science in Applied Finance from the Singapore Management University. He holds the CFTe and FRM certifications and is a CFA charterholder.

He was ranked #2 Top Stock Picker (Asia) for Real Estate Investment Trusts in the 2018 Thomson Reuters Analyst Awards, and ranked #2 Top Stock Picker (Singapore) for Resources & Infrastructure in the 2016 Thomson Reuters Analyst Awards.

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!